Investigation of Post Vaccination Reactions of Two Live Attenuated Vaccines against Lumpy Skin Disease of Cattle

被引:30
作者
Bamouh, Zahra [1 ,2 ]
Hamdi, Jihane [1 ,2 ]
Fellahi, Siham [2 ]
Khayi, Slimane [3 ]
Jazouli, Mohammed [1 ]
Tadlaoui, Khalid Omari [1 ]
Fihri, Ouafaa Fassi [2 ]
Tuppurainen, Eeva [4 ]
Elharrak, Mehdi [1 ]
机构
[1] MCI Sante Anim, Mohammadia 28810, Morocco
[2] Inst Agron & Vet Hassan II, BP 6202, Rabat 10112, Morocco
[3] Natl Inst Agr Res INRA, CRRA Rabat, Rabat 10101, Morocco
[4] Friedrich Loeffler Inst Fed Res Inst Anim Hlth, Inst Int Tiergesundheit One Hlth, D-17493 Greifswald, Germany
关键词
lumpy skin disease virus; safety; Neethling disease; vaccination; cattle; ADVERSE-REACTIONS; VIRUS; TRANSMISSION; OUTBREAK; EFFICACY; STRAIN; SHEEP;
D O I
10.3390/vaccines9060621
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lumpy skin disease virus (LSDV) causes an economically important disease in cattle. The only method for successful control is early diagnosis and efficient vaccination. Adverse effects of vaccination such as local inflammation at the injection site and localized or generalized skin lesions in some vaccinated animals have been reported with live vaccines. The aim of this work was to compare the safety of two lumpy skin disease (LSD) vaccine strains, Kenyan (Kn) Sheep and Goat Pox (KSGP O-240) and LSDV Neethling (Nt) strain, and to determine the etiology of the post-vaccination (pv) reactions observed in cattle. Experimental cattle were vaccinated under controlled conditions with Nt- and KSGP O-240-based vaccines, using two different doses, and animals were observed for 3 months for any adverse reactions. Three out of 45 cattle vaccinated with LSDV Nt strain (6.7%) and three out of 24 cattle vaccinated with Kn strain (12.5%) presented LSD-like skin nodules, providing evidence that the post-vaccination lesions may not be strain-dependent. Lesions appeared 1-3 weeks after vaccination and were localized in the neck or covering the whole body. Animals recovered after 3 weeks. There is a positive correlation between the vaccine dose and the appearance of skin lesions in vaccinated animals; at the 105 dose, 12% of the animals reacted versus 3.7% at the 104 dose. Both strains induced solid immunity when protection was measured by neutralizing antibody seroconversion.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease
    Sanchez-Valdez, Fernando J.
    Perez Brandan, Cecilia
    Ferreira, Arturo
    Angel Basombrio, Miguel
    EXPERT REVIEW OF VACCINES, 2015, 14 (05) : 681 - 697
  • [42] Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4
    Veronesi, Eva
    Darpel, Karin E.
    Hamblin, Chris
    Carpenter, Simon
    Takamatsu, Haru-Hisa
    Anthony, Simon J.
    Elliott, Heather
    Mertens, Peter P. C.
    Mellor, Philip S.
    VACCINE, 2010, 28 (05) : 1397 - 1403
  • [43] Serological Responses in Cattle following Booster Vaccination against Serotypes 4 and 8 Bluetongue Virus with Two Bivalent Commercial Inactivated Vaccines
    Sailleau, Corinne
    Postic, Lydie
    Chatenet, Xavier
    Salat, Olivier
    Turpaud, Mathilde
    Durand, Benoit
    Vitour, Damien
    Zientara, Stephan
    Breard, Emmanuel
    VIRUSES-BASEL, 2022, 14 (12):
  • [44] Two Live Attenuated Vaccines against Recent Low-and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
    Rudenko, Larisa
    Kiseleva, Irina
    Krutikova, Elena
    Stepanova, Ekaterina
    Isakova-Sivak, Irina
    Donina, Svetlana
    Rekstin, Andrey
    Pisareva, Maria
    Bazhenova, Ekaterina
    Kotomina, Tatiana
    Katelnikova, Anastasia
    Muzhikyan, Arman
    Makarov, Valery
    Sparrow, Erin Grace
    Torelli, Guido
    VACCINES, 2018, 6 (04):
  • [45] Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
    Pieter T. de Boer
    Alies van Lier
    Hester de Melker
    Albert J. M. van Wijck
    Jan C. Wilschut
    Albert Jan van Hoek
    Maarten J. Postma
    BMC Medicine, 16
  • [46] Development of in-house ELISA for detection of antibodies against lumpy skin disease virus in cattle and assessment of its performance using a bayesian approach
    Sthitmatee, Nattawooti
    Tankaew, Pallop
    Modethed, Wittawat
    Rittipornlertrak, Amarin
    Muenthaisong, Anucha
    Apinda, Nisachon
    Koonyosying, Pongpisid
    Nambooppha, Boondarika
    Chomjit, Paweena
    Sangkakam, Kanokwan
    Singhla, Tawatchai
    Vinitchaikul, Paramintra
    Boonsri, Kittikorn
    HELIYON, 2023, 9 (02)
  • [47] Development of a Synthesized Gene Unique to Lumpy Skin Disease Virus and Its Application in Serological Differentiation of Naturally Infected from Vaccinated Cattle with Attenuated Goat Pox Vaccine
    Yuan, Xinwei
    Zhang, Haoyun
    Wang, Yu
    Wu, Di
    Shirani, Ihsanullah
    Chen, Yingyu
    Chen, Jianguo
    Chen, Xi
    Zhang, Lei
    Chen, Huanchun
    Hu, Changmin
    Guo, Aizhen
    TRANSBOUNDARY AND EMERGING DISEASES, 2024, 2024
  • [48] EVALUATING THE PROTECTIVE EFFICACY OF A LIVE AND TWO KILLED VACCINES AGAINST INFECTIOUS BURSAL DISEASE IN COMMERCIAL CHICKS IN ZARIA, NIGERIA
    Angani, M. T.
    Abdu, P. A.
    Sa'idu, L.
    JOURNAL OF EXPERIMENTAL BIOLOGY AND AGRICULTURAL SCIENCES, 2014, 2 (01): : 58 - 64
  • [49] Field trial of the effect of vaccination against Bovine herpesvirus 1 on milk yield and rumination time: comparison between two live marker vaccines
    Stradaioli, Giuseppe
    Sorgia, Emanuela
    Soriolo, Adriano
    Corazzin, Mirco
    LARGE ANIMAL REVIEW, 2023, 29 (02): : 79 - 82
  • [50] Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens
    Ferreira, Helena L.
    Reilley, Alexandra M.
    Goldenberg, Dana
    Ortiz, Ivan R. A.
    Gallardo, Rodrigo A.
    Suarez, David L.
    VACCINE, 2020, 38 (34) : 5507 - 5515